content

Abveris, Inc., and Abilita Bio, Inc., both privately held biotechnology companies, announce a joint research collaboration that will leverage the synergies between their platforms...

India’s first mRNA-based COVID-19 vaccine candidate HGCO19 by Gennova Biopharmaceuticals Ltd has been granted approval for Phase 2/3 clinical trials, the Department of Biotechnology...

Sorrento Therapeutics, Inc., a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain and COVID-19. The publication details preclinical vaccination...

Jardiance® (empagliflozin) 10 mg has been approved by the U.S. Food and Drug Administration to reduce the risk of cardiovascular death plus hospitalization for...

Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and the industry’s most robust and expansive lipid nanoparticle (LNP) patent estate, announced...

DKSH Business Unit Healthcare has entered into a partnership with Medigen Vaccine Biologics Corporation to ensure that their COVID-19 vaccines are speedily delivered and...

Regeneron Pharmaceuticals, Inc. announced that the United Kingdom's (UK) Medicines and Healthcare products Regulatory Agency (MHRA) has granted Conditional Marketing Authorization (CMA) for the...